Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Secretary/CEO of subsidiary
-
Issuer Symbol
-
TXMD on Nasdaq
There are no Buy or Sell transactions made by John C.K. Milligan IV since 12 Feb 2025
Holdings reported by John C.K. Milligan IV for TherapeuticsMD, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3,582,373 |
$8,020,933 |
$2.24 |
10 May 2021 |
Indirect |
|
|
| Common Stock |
1,752,703 |
$3,924,302 |
$2.24 |
11 May 2021 |
Direct |
|
|
| Restricted Stock Units |
207,000 |
$753,087 |
$3.64 |
10 May 2021 |
Direct |
Common Stock |
|
Transactions reported by John C.K. Milligan IV for TherapeuticsMD, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.